Evidence check: FOXO3 in the context of Allergie

The role of FOXO3 in allergy is not well-established. FOXO3 is a transcription factor involved in longevity, oxidative stress, and immune regulation. Some GWAS and candidate gene studies have linked FOXO3 variants (e.g., rs2764264) to human lifespan, but evidence for a direct connection to allergic conditions like asthma, rhinitis, or atopy is limited and inconsistent. Most robust data come from centenarian studies, not allergy cohorts. MyBody-X DNA tests can detect such variants, but results are educational only—not diagnostic. A positive finding does not predict allergy risk or severity. Environmental factors, diet, and microbiome are far more influential. Caution: overinterpreting a single FOXO3 SNP for allergy management is not supported by current evidence. Evidence grade: mixed (human-observational for longevity, mechanistic for immune pathways, but no strong allergy-specific validation).